Advanced search
Add to list

WRN Promoter CpG island hypermethylation does not predict a favourable outcome for irinotecan-treated metastatic colorectal cancer patients

(2015) JOURNAL OF PATHOLOGY. 237(suppl. 1). p.S40-S40
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Bosch, LJW, et al. “WRN Promoter CpG Island Hypermethylation Does Not Predict a Favourable Outcome for Irinotecan-Treated Metastatic Colorectal Cancer Patients.” JOURNAL OF PATHOLOGY, vol. 237, no. suppl. 1, 2015, pp. S40–S40.
APA
Bosch, L., Luo, Y., Lao, V., Snaebjornsson, P., Trooskens, G., Vlassenbroeck, I., … Grady, W. (2015). WRN Promoter CpG island hypermethylation does not predict a favourable outcome for irinotecan-treated metastatic colorectal cancer patients. JOURNAL OF PATHOLOGY, 237(suppl. 1), S40–S40.
Chicago author-date
Bosch, LJW, Y Luo, VV Lao, P Snaebjornsson, Geert Trooskens, I Vlassenbroeck, S Mongera, et al. 2015. “WRN Promoter CpG Island Hypermethylation Does Not Predict a Favourable Outcome for Irinotecan-Treated Metastatic Colorectal Cancer Patients.” In JOURNAL OF PATHOLOGY, 237:S40–S40.
Chicago author-date (all authors)
Bosch, LJW, Y Luo, VV Lao, P Snaebjornsson, Geert Trooskens, I Vlassenbroeck, S Mongera, W Tang, P Welcsh, J Herman, M Koopman, I Nagtegaal, CJA Punt, Wim Van Criekinge, GA Meijer, RJ Monnat, B Carvalho, and WM Grady. 2015. “WRN Promoter CpG Island Hypermethylation Does Not Predict a Favourable Outcome for Irinotecan-Treated Metastatic Colorectal Cancer Patients.” In JOURNAL OF PATHOLOGY, 237:S40–S40.
Vancouver
1.
Bosch L, Luo Y, Lao V, Snaebjornsson P, Trooskens G, Vlassenbroeck I, et al. WRN Promoter CpG island hypermethylation does not predict a favourable outcome for irinotecan-treated metastatic colorectal cancer patients. In: JOURNAL OF PATHOLOGY. 2015. p. S40–S40.
IEEE
[1]
L. Bosch et al., “WRN Promoter CpG island hypermethylation does not predict a favourable outcome for irinotecan-treated metastatic colorectal cancer patients,” in JOURNAL OF PATHOLOGY, Dublin, Ireland, 2015, vol. 237, no. suppl. 1, pp. S40–S40.
@inproceedings{7154430,
  author       = {{Bosch, LJW and Luo, Y and Lao, VV and Snaebjornsson, P and Trooskens, Geert and Vlassenbroeck, I and Mongera, S and Tang, W and Welcsh, P and Herman, J and Koopman, M and Nagtegaal, I and Punt, CJA and Van Criekinge, Wim and Meijer, GA and Monnat, RJ and Carvalho, B and Grady, WM}},
  booktitle    = {{JOURNAL OF PATHOLOGY}},
  issn         = {{0022-3417}},
  language     = {{eng}},
  location     = {{Dublin, Ireland}},
  number       = {{suppl. 1}},
  pages        = {{S40--S40}},
  title        = {{WRN Promoter CpG island hypermethylation does not predict a favourable outcome for irinotecan-treated metastatic colorectal cancer patients}},
  volume       = {{237}},
  year         = {{2015}},
}

Web of Science
Times cited: